Temple, the wearable technology startup founded by Zomato co-founder Deepinder Goyal, is facing growing scrutiny from doctors and clinical scientists over the scientific evidence behind its health-monitoring technology. The device, worn on the side of the forehead, uses optical sensors to track physiological signals and offers proprietary measurements called BrainFlow and Entropy. Although early company-funded studies have reported promising results, medical experts say important questions remain about whether the device can reliably measure blood circulation inside the brain and provide meaningful insights into human health and ageing.
The controversy has intensified after Temple opened pre-orders in India on November 1, 2026, at a price of ₹85,000. Goyal has defended the technology, describing it as a fitness and wellness wearable rather than a medical diagnostic device. He says the company is continuing to validate its measurements and has offered researchers access to the device for independent testing. However, doctors argue that preliminary correlations and internal studies are not enough to establish the accuracy or clinical usefulness of a new health metric. The disagreement highlights a broader challenge for health technology startups: demonstrating that innovative sensors can produce scientifically reliable information before making ambitious claims about the human body.
Key Takeaways
- Temple is a forehead-worn wearable developed by Deepinder Goyal’s health-tech startup.
- The device costs ₹85,000 in India, with pre-orders opening on November 1, 2026.
- Its two main proprietary measurements are BrainFlow and Entropy.
- Two company-funded preprints have reported promising BrainFlow results under controlled conditions.
- The studies have not been peer-reviewed or independently replicated.
- Doctors question whether a sensor near the superficial temporal artery can reliably measure blood flow inside the brain.
- Goyal says Temple is a fitness and wellness product, not a medical diagnostic device.
- Independent validation remains important before its measurements can be treated as established health indicators.
What Is Deepinder Goyal’s Temple Wearable?
Temple is a health and fitness technology product designed to monitor physiological signals continuously through sensors placed near the side of the forehead.
Unlike conventional smartwatches that are generally worn on the wrist, Temple uses a different placement to collect optical signals from the temple region.
The device uses photoplethysmography (PPG), an optical sensing technology that detects changes in blood volume by measuring variations in light absorption.
PPG technology is already used in several consumer wearables to estimate measurements such as heart rate and blood-related signals.
Temple aims to extend this approach through proprietary measurements intended to provide additional information about the body’s physiological condition.
Its two principal metrics are:
| Metric | What Temple says it measures |
|---|---|
| BrainFlow | Relative changes in blood circulation associated with the brain |
| Entropy | A proprietary score intended to represent the body’s physiological workload |
The device is also connected to Goyal’s broader interest in longevity, human performance and understanding how the body responds to everyday activities.
However, detecting physiological signals and proving that they accurately represent specific biological processes are two different scientific challenges.
What Is BrainFlow and Why Are Doctors Questioning It?
BrainFlow is Temple’s proprietary measurement designed to track relative changes in blood circulation associated with the brain.
The company says the metric can continuously monitor changes that may provide insights into cerebral circulation.
The central scientific question is whether a sensor positioned near the forehead can distinguish blood-flow changes occurring in the brain from changes in the scalp and surrounding tissues.
Temple’s optical sensors are positioned near the superficial temporal artery, which supplies blood to parts of the scalp and face.
However, the brain receives most of its blood supply through two major arterial systems:
- The internal carotid arteries.
- The vertebral arteries.
These arteries supply blood to the brain through a different vascular system from the superficial temporal artery.
Doctors argue that changes in blood flow through the scalp do not necessarily correspond to changes inside the brain.
For example, during exercise, blood flow to the skin can increase as the body attempts to regulate temperature. A forehead sensor may detect changes in local blood circulation, but that does not automatically establish that cerebral blood flow has changed in the same way.
This is the central anatomical concern raised by several medical experts.
The question is not simply whether Temple can detect a signal. It is whether the signal accurately represents the biological process the company associates with it.
What Do Temple’s Early Studies Show?
Temple has published two company-funded preprints examining its BrainFlow measurement.
A preprint is a scientific manuscript made publicly available before formal peer review. It allows researchers to examine and discuss findings, but it does not mean the results have passed independent scientific scrutiny.
According to the studies and Goyal’s public explanations, the device was tested against established measurement techniques under controlled physiological conditions.
One comparison involved time-domain near-infrared spectroscopy, a technology that can help distinguish changes in blood volume associated with the brain from changes in the scalp.
Goyal said the second preprint reported a correlation of 0.91 between Temple’s BrainFlow signal and the brain-related reference signal, compared with 0.49 for the scalp-related signal during a head-down tilt experiment.
He has also referred to comparisons involving transcranial Doppler measurements, which assess blood-flow velocity in major cerebral arteries.
These results are potentially interesting because they suggest that the device may capture signals associated with changes in cerebral circulation.
However, correlation does not automatically prove that a wearable directly measures blood flow inside the brain.
The studies also need to be assessed for sample size, participant diversity, methodology, signal processing, measurement accuracy and reproducibility.
Most importantly, independent researchers need to reproduce the findings before the measurements can be considered scientifically established.
Why Are Doctors Questioning the Scientific Evidence?
Several medical experts have questioned whether Temple’s publicly available research supports the claims associated with the device.
One concern relates to the difference between measuring a physiological signal and establishing a clinically meaningful measurement.
A wearable may detect changes in blood circulation during exercise, sleep or changes in posture. However, this does not automatically mean that its readings can accurately measure brain health or predict future medical outcomes.
Doctors have raised several questions:
- Does BrainFlow accurately measure cerebral circulation rather than superficial scalp blood flow?
- Can the readings remain reliable across different individuals and physiological conditions?
- Are the results consistent across different age groups and genders?
- Does the device provide information beyond existing fitness and medical monitoring technologies?
- Can changes in its readings be connected to meaningful improvements in health?
Medical experts have also questioned the limited availability of independently replicated evidence.
The controversy is therefore not simply about whether Temple is an interesting piece of technology. It is about whether the scientific claims attached to its measurements are supported by sufficiently strong evidence.
What Is Entropy? Temple’s Other Major Health Metric
Entropy is another central feature of Temple.
Goyal describes it as a proprietary measurement intended to indicate how hard the body is working to sustain itself.
The score ranges from 1 to 250, with lower readings associated with deeper rest and higher readings associated with greater physiological exertion.
According to the company, the measurement can respond to several everyday activities and conditions, including:
- Sleep and recovery.
- Physical exercise.
- Psychological stress.
- Food consumption.
- Caffeine intake.
- Meditation.
- Other changes in physiological activity.
The broader ambition is to provide users with a continuous measure of their body’s internal workload.
However, doctors have questioned whether Entropy has been established as a scientifically valid biomarker.
A biomarker is a measurable biological characteristic that can provide information about a physiological condition or biological process.
For a new metric to qualify as a reliable biomarker, researchers need to establish what it measures, how it is calculated, how consistently it performs and whether it offers useful information beyond existing measurements.
Temple’s Entropy score has not yet been independently established as a validated measure of metabolism, biological ageing or longevity.
A score changing during exercise or meditation is not sufficient to demonstrate that it can predict how long someone will live or how quickly they are ageing.
Can Temple Actually Measure Biological Ageing?
One of the broader questions surrounding the product comes from Goyal’s interest in the relationship between gravity, blood circulation and ageing.
His Gravity Ageing Hypothesis proposes that spending prolonged periods upright may affect blood circulation to the brain and potentially contribute to ageing.
The idea has attracted scientific criticism because the human body already has mechanisms that help regulate blood supply to the brain.
One of these mechanisms is cerebral autoregulation.
It helps maintain relatively stable blood flow to brain tissue despite changes in blood pressure and body position.
Although cerebral blood-flow patterns can change with age and posture, establishing that decades of standing upright cause brain ageing requires much stronger evidence.
Doctors have also cautioned against drawing practical health recommendations from an unproven hypothesis.
For example, inversion or head-down positioning can increase pressure inside the eyes and skull. Such activities may be unsuitable for people with certain medical conditions, including glaucoma and some cardiovascular or cerebrovascular disorders.
Temple’s current measurements should therefore not be interpreted as proof that a person can slow ageing by changing posture or following a particular Entropy score.
Deepinder Goyal Defends Temple Against Medical Criticism
Goyal has publicly defended the technology following criticism from doctors and researchers.
He argues that Temple is a fitness and wellness product rather than a medical diagnostic device.
He has also said that its metrics are still undergoing validation and that the company intends to make further scientific evidence available.
Goyal has challenged critics to examine the underlying studies rather than dismiss the product before independent testing.
He has also offered to provide devices to qualified researchers who want to evaluate its measurements independently.
On the pricing question, Goyal has defended the ₹85,000 price by pointing to the research and development investment behind the product.
He has said customers who remain uncertain can wait for independent user reviews before deciding whether the device is worth purchasing.
The founder has also acknowledged that some of his public responses to doctors could have been handled better and apologised for generalising about the medical community.
The disagreement reflects a wider tension between technology founders who want to introduce new products quickly and medical professionals who expect strong evidence before accepting claims involving human health.
How Much Does Temple Cost and When Will It Be Available?
Temple opened pre-orders in India on November 1, 2026.
The wearable is priced at ₹85,000, placing it in the premium segment of the consumer health and fitness technology market.
Deliveries are expected to begin approximately three months after pre-orders opened.
| Product detail | Information |
|---|---|
| Product | Temple wearable |
| Founder | Deepinder Goyal |
| Technology | Optical sensing using PPG |
| Main measurements | BrainFlow and Entropy |
| India pre-order date | November 1, 2026 |
| Price | ₹85,000 |
| Expected delivery | Approximately three months after pre-orders |
| Product positioning | Fitness and wellness device |
The company has also introduced a 14-day no-questions-asked return policy, according to Goyal’s public statements.
However, buyers should examine the company’s actual purchase terms, delivery conditions and return policy before placing an order.
The device’s premium pricing makes scientific transparency and independently verified performance particularly important considerations for potential customers.
Is Temple a Medical Device or a Fitness Wearable?
This is another important question raised by the controversy.
Goyal has repeatedly said that Temple is not a medical device and does not diagnose or prevent diseases.
Instead, he positions it as a fitness and wellness wearable.
However, legal and regulatory experts have noted that a company’s description of its product does not necessarily determine its regulatory classification.
The intended purpose, product functionality, measurements and claims made to consumers can all be relevant.
A wearable that measures general fitness parameters may be treated differently from a product marketed for diagnosing or monitoring a specific medical condition.
For Temple, the distinction will become increasingly important if future marketing claims move beyond general wellness and begin making specific medical or diagnostic assertions.
Goyal has said that regulatory clearances will be obtained before the company makes claims requiring them.
What Does the Temple Controversy Mean for India’s Health-Tech Industry?
The Temple debate is significant beyond one startup because it highlights the growing intersection between artificial intelligence, wearable technology and healthcare.
Companies are increasingly developing devices that promise to measure more than conventional fitness indicators.
These products aim to provide information about recovery, stress, metabolic activity, sleep, brain function and longevity.
The opportunity is substantial, but the industry also faces several challenges.
Scientific validation: New health measurements need transparent methodologies and independent testing.
Consumer protection: Buyers should understand what a device can reliably measure and what remains experimental.
Regulatory clarity: Companies need to distinguish general wellness products from devices making medical claims.
Data reliability: Measurements should be tested across different populations, conditions and usage environments.
Responsible marketing: Startups should avoid presenting preliminary findings as established scientific breakthroughs.
The Temple controversy illustrates why innovation in health technology must be accompanied by evidence, transparency and appropriate communication.
The Bigger Picture
Temple represents an ambitious attempt to expand the capabilities of wearable technology beyond conventional fitness tracking. Its forehead-based sensing approach and proprietary measurements could become interesting areas of research if the company can demonstrate that they provide reliable information about human physiology. However, the gap between detecting a biological signal and establishing a scientifically validated health metric remains significant.
The coming months will be important as Temple moves from a limited early-access environment towards broader availability. Independent studies, peer-reviewed research and transparent explanations of its measurement methods will determine how much confidence consumers and medical professionals can place in the technology. For India’s growing health-tech industry, the controversy is a reminder that an innovative product may attract attention through bold ideas, but long-term credibility depends on reproducible scientific evidence.
Frequently Asked Questions
1. What is Deepinder Goyal’s Temple wearable?
Temple is a forehead-worn fitness and wellness device developed by Deepinder Goyal. It uses optical sensors to collect physiological signals and provides proprietary measurements called BrainFlow and Entropy.
2. How much does Temple cost in India?
Temple opened pre-orders in India on November 1, 2026, at a price of ₹85,000.
3. What is BrainFlow in Temple?
BrainFlow is a proprietary measurement designed to track relative changes in blood circulation associated with the brain. Its accuracy and clinical significance still require further independent validation.
4. What is the Entropy score?
Entropy is a proprietary score ranging from 1 to 250 that Temple says represents the body’s physiological workload. The metric has not yet been independently established as a validated biomarker for metabolism or longevity.
5. Why are doctors questioning Temple?
Doctors are questioning whether a forehead-mounted optical sensor can reliably distinguish blood flow in the scalp from circulation inside the brain. They also want more transparent methodology, peer-reviewed studies and independent replication.
6. Have Temple’s scientific studies been peer-reviewed?
The two company-funded preprints discussed in the November 2026 reports have not been peer-reviewed or independently replicated.
7. Is Temple a medical device?
Goyal describes Temple as a fitness and wellness device, not a medical diagnostic product. Its regulatory classification depends on its intended purpose, functionality and claims, rather than the company’s description alone.
8. Can Temple predict how long someone will live?
There is currently no established independent evidence demonstrating that Temple can predict an individual’s lifespan or reliably measure biological ageing.
Looking Ahead
Temple’s next major test will be independent scientific validation. Researchers will need to examine whether its BrainFlow measurements accurately represent cerebral circulation, whether its Entropy score provides reliable physiological information and whether the results can be reproduced across different populations. Peer-reviewed publications and transparent testing will be important in determining whether the company’s claims can withstand medical scrutiny.
For Deepinder Goyal, the challenge is to turn an ambitious wearable concept into a product supported by convincing evidence. For consumers, the sensible approach is to distinguish between the device’s existing fitness features and its more ambitious scientific claims. Until stronger evidence becomes available, Temple should be viewed as an experimental wellness technology rather than a proven tool for measuring brain health, predicting longevity or diagnosing medical conditions.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
